Close



Apr 11, 2024 08:05AM
Apr 3, 2024 08:05AM
Apr 3, 2024 08:05AM
Feb 22, 2024 07:30AM
Feb 21, 2024 08:06AM
Feb 21, 2024 08:05AM
Feb 20, 2024 08:05AM Harmony Biosciences (HRMY) Receives U.S. Food And Drug Administration Orphan Drug Designation For Pitolisant In Prader-willi Syndrome
Feb 20, 2024 08:05AM
Jan 8, 2024 08:17AM
Jan 8, 2024 08:05AM
Dec 7, 2023 08:06AM
Dec 7, 2023 08:05AM
Dec 5, 2023 08:05AM
Oct 31, 2023 07:30AM Harmony Biosciences Reports Strong Third Quarter 2023 Financial Results
Oct 13, 2023 08:13AM
Oct 13, 2023 08:01AM
Oct 13, 2023 08:00AM
Oct 11, 2023 08:02AM
Oct 11, 2023 08:00AM
Oct 5, 2023 08:05AM
Oct 5, 2023 08:05AM HARMONY BIOSCIENCES PRESENTS NEW SECONDARY OUTCOME DATA FROM PHASE 2 SIGNAL DETECTION STUDY IN PATIENTS WITH PRADER-WILLI SYNDROME
Sep 20, 2023 08:05AM
Sep 7, 2023 08:07AM
Sep 7, 2023 08:05AM
Aug 28, 2023 08:01AM
Aug 28, 2023 08:00AM
Aug 14, 2023 07:31AM
Aug 14, 2023 07:30AM HARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.
Aug 1, 2023 07:30AM
Jul 25, 2023 08:05AM
Jul 20, 2023 08:06AM
Jul 20, 2023 08:05AM
Jun 19, 2023 09:00PM
Jun 6, 2023 08:06AM
Jun 6, 2023 08:05AM HARMONY BIOSCIENCES ANNOUNCES POSITIVE PHASE 2 SIGNAL DETECTION STUDY EVALUATING PITOLISANT FOR EXCESSIVE DAYTIME SLEEPINESS IN PRADER-WILLI SYNDROME AT SLEEP 2023
May 25, 2023 08:05AM
May 10, 2023 08:05AM
May 2, 2023 07:30AM
May 2, 2023 07:30AM
Apr 24, 2023 08:08AM
Apr 24, 2023 08:05AM
Apr 23, 2023 09:00PM Bragar Eagel & Squire, P.C. Is Investigating LivePerson, and Harmony and Encourages Investors to Contact the Firm
Apr 12, 2023 09:00PM
Apr 2, 2023 09:00PM
Mar 29, 2023 08:05AM
Mar 29, 2023 08:05AM
Mar 28, 2023 01:04PM
Mar 28, 2023 09:56AM
Feb 21, 2023 07:30AM Harmony Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates
Feb 21, 2023 07:30AM

251,761 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All